Skip to main content
In stock|Targeted Therapy

Entospletinib

Oncology TypeHematologic
Drug Class / MechanismSYK / Multi-Kinase Inhibitor
No Image
Description

Entospletinib is classified as a SYK / Multi-Kinase Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeHematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3